We invite researchers, clinicians, academicians, policy-makers, and healthcare professionals to submit original and impactful manuscripts to the Asian Journal of Advances in Orphan Pharmacotherapy (AJAOP)—a dedicated platform for scholarly communication on rare diseases and orphan drug development across Asia and beyond.
Areas of Interest Include
- Innovative therapies for rare and ultra-rare diseases
- Drug repurposing for orphan indications
- Clinical trials and compassionate use programs
- Pharmacovigilance and safety in orphan pharmacotherapy
- Health economics and access to orphan drugs
- Pediatric rare disease management
- Genomic approaches to rare diseases
- Regulatory perspectives and global frameworks
- Regional case studies and healthcare disparities
Submission Guidelines
- Manuscripts should be prepared according to the Instructions for Authors provided on our website.
- Submissions should be original and not under consideration for publication elsewhere.
- All submissions are subject to a rigorous peer review process to ensure the highest quality and integrity of the content.
- Accepted papers will be published in upcoming issues of the journal.
Submission Process
To submit your manuscript:
- Online Submission: Please submit your manuscript through our [online submission system].
- Review Timeframe: You will receive a response within 2-3 working days, and your paper will be reviewed within 8 days.
- Notification: You will receive acceptance or rejection notification within 22 days of submission.
Why Publish with AJAOP?
- Fast-track peer review and decision process
- Global visibility with open access
- Indexed submission for wider academic reach
- No processing fees for the initial issues
- Committed to advocacy and awareness in the rare disease community
Contact Us
For queries related to submissions or the journal’s scope, please email us.
